noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

UCSD - University of California -[...]

Large Genetic Study Links Cannabis Use to Psychiatric, Cognitive and[...]
UCSD - University of California -[...]

Spanish-Language Counseling Cuts Heavy Drinking Among Latinx Adults by[...]
Omada Health Inc.

Omada Introduces Nutritional Intelligence to Transform Food[...]

Healthcare

AnaptysBio Inc.

10/13/2025 | Press release | Distributed by Public on 10/13/2025 07:19

Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025

You don't have permission to access "http://ir.anaptysbio.com/news-releases/news-release-details/anaptys-announces-late-breaking-oral-presentation-complete-phase" on this server.

Reference #18.c7ab3717.1760361598.32ae01bb

https://errors.edgesuite.net/18.c7ab3717.1760361598.32ae01bb

AnaptysBio Inc. published this content on October 13, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 13, 2025 at 13:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]